Washington University School of Medicine

Digital Commons@Becker
Open Access Publications
2012

Geminin regulates the transcriptional and epigenetic status of
neuronal fate-promoting genes during mammalian neurogenesis
Dhananjay Yellajoshyula
Washington University School of Medicine in St. Louis

Jong-won Lim
Washington University School of Medicine in St. Louis

Dominic M. Thompson
Washington University School of Medicine in St. Louis

Jacob S. Witt
Washington University School of Medicine in St. Louis

Ethan S. Patterson
Washington University School of Medicine in St. Louis

See next page for additional authors

Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs

Recommended Citation
Yellajoshyula, Dhananjay; Lim, Jong-won; Thompson, Dominic M.; Witt, Jacob S.; Patterson, Ethan S.; and
Kroll, Kristen L., ,"Geminin regulates the transcriptional and epigenetic status of neuronal fate-promoting
genes during mammalian neurogenesis." Molecular and Cellular Biology. 32,22. 4549-4560. (2012).
https://digitalcommons.wustl.edu/open_access_pubs/2068

This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been
accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker.
For more information, please contact vanam@wustl.edu.

Authors
Dhananjay Yellajoshyula, Jong-won Lim, Dominic M. Thompson, Jacob S. Witt, Ethan S. Patterson, and
Kristen L. Kroll

This open access publication is available at Digital Commons@Becker: https://digitalcommons.wustl.edu/
open_access_pubs/2068

Geminin Regulates the Transcriptional and
Epigenetic Status of Neuronal
Fate-Promoting Genes during Mammalian
Neurogenesis
Dhananjay Yellajoshyula, Jong-won Lim, Dominic M.
Thompson Jr., Jacob S. Witt, Ethan S. Patterson and
Kristen L. Kroll
Mol. Cell. Biol. 2012, 32(22):4549. DOI:
10.1128/MCB.00737-12.
Published Ahead of Print 4 September 2012.

These include:
SUPPLEMENTAL MATERIAL
REFERENCES

CONTENT ALERTS

Supplemental material
This article cites 32 articles, 10 of which can be accessed free
at: http://mcb.asm.org/content/32/22/4549#ref-list-1
Receive: RSS Feeds, eTOCs, free email alerts (when new
articles cite this article), more»

Information about commercial reprint orders: http://journals.asm.org/site/misc/reprints.xhtml
To subscribe to to another ASM Journal go to: http://journals.asm.org/site/subscriptions/

Downloaded from http://mcb.asm.org/ on January 11, 2014 by guest

Updated information and services can be found at:
http://mcb.asm.org/content/32/22/4549

Geminin Regulates the Transcriptional and Epigenetic Status of
Neuronal Fate-Promoting Genes during Mammalian Neurogenesis
Dhananjay Yellajoshyula,* Jong-won Lim,* Dominic M. Thompson, Jr.,* Jacob S. Witt, Ethan S. Patterson, and Kristen L. Kroll
Department of Developmental Biology, Washington University School of Medicine, St. Louis, Missouri, USA

T

ranscriptional and epigenetic control of neuronal gene expression plays a major role in the temporal and spatial regulation
of nervous system development. Developmental genes, including
those regulating neurogenesis and neuronal commitment and differentiation, are maintained in a repressive chromatin context
through the activity of the Polycomb (PcG) repressor complex.
PcG catalyzes a repressive chromatin modification (trimethylation of histone H3 lysine 27 [H3K27me3]) at genes involved in cell
specification and differentiation to prevent their premature expression in embryonic stem (ES) cells (2). At developmental genes
in both pluripotent stem and multipotent precursor cells, this
repressive modification is frequently accompanied by the
H3K4me3 histone modification, which is catalyzed by mixed-lineage leukemia (MLL) complexes and promotes active transcription (2, 16). Together, this bivalent combination of activating and
repressive histone modifications retains developmental genes in a
poised but repressed state (1, 14). During neurogenesis, this chromatin state changes at genes encoding factors that drive neuronal
specification, commitment, and differentiation to promote their
expression. Concomitant with high levels of transcription, the repressive H3K27me3 modification is lost, while the locus becomes
highly enriched for H3K4me3 and histone acetylation, which promote target gene transactivation (16). These chromatin state
changes are likely to facilitate the activities of the neural basic
helix-loop-helix (bHLH) transcription factors, which play critical
roles in activating gene programs that drive neurogenesis and neuronal differentiation.
Among the potential regulators of gene expression during neurogenesis, there is increasing evidence for the active involvement
of the small nucleoprotein geminin (Gmnn or Gem). Gem was
initially identified as a dual-function protein that promotes neural
fate acquisition in the Xenopus embryo (9) and controls the fidelity of DNA replication (13), through its physical interaction with
and functional antagonism of Cdt1 (25, 27). Gem is highly expressed in early embryonic tissues in vertebrates and plays a role in
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regulating multiple developmental processes, including maintenance of the pluripotent cell state (5, 11, 28) and control of neural
cell fate acquisition from pluripotent cells (9, 17, 20, 30). In the
nervous system, Gem is highly expressed in early neural precursor
cells (20, 23, 30). As committed neuronal precursor cells receive
spatial and temporal cues to differentiate into postmitotic neurons, geminin expression is downregulated in concert with other
neural progenitor-specific markers (20, 23). In Xenopus, forced
expression of geminin at these stages antagonizes the expression of
markers of terminal neuronal differentiation, such as neuron-specific ␤-III tubulin, while neural progenitor marker expression is
retained (20). Therefore, in Xenopus, geminin plays a role in promoting initial neural fate acquisition while maintaining the neural
precursor state and preventing terminal neuronal differentiation.
Studies to assess the role of geminin in mammalian neurogenesis and neural stem cell (NSC) maintenance have yielded mixed
information. Loss of geminin in cortical neural progenitor cells
(NPCs) surprisingly resulted in increases in NPC cell number and
in decreased production of neurons in ventricular zone regions,
suggesting a positive role for geminin in promoting cortical neu-

Received 1 June 2012 Returned for modification 25 June 2012
Accepted 30 August 2012
Published ahead of print 4 September 2012
Address correspondence to Kristen L. Kroll, kkroll@wustl.edu.
* Present address: Dhananjay Yellajoshyula, Department of Neurology, University
of Michigan, Ann Arbor, Michigan, USA; Jong-won Lim, Human Biology Division,
Fred Hutchinson Cancer Research Center, Seattle, Washington, USA; Dominic M.
Thompson, Jr., Division of Endocrine and Oncologic Surgery, Department of
Surgery, Washington University School of Medicine and Siteman Cancer Center,
St. Louis, Missouri, USA.
Supplemental material for this article may be found at http://mcb.asm.org/.
Copyright © 2012, American Society for Microbiology. All Rights Reserved.
doi:10.1128/MCB.00737-12

Molecular and Cellular Biology

p. 4549 – 4560

mcb.asm.org

4549

Downloaded from http://mcb.asm.org/ on January 11, 2014 by guest

Regulating the transition from lineage-restricted progenitors to terminally differentiated cells is a central aspect of nervous system development. Here, we investigated the role of the nucleoprotein geminin in regulating neurogenesis at a mechanistic level
during both Xenopus primary neurogenesis and mammalian neuronal differentiation in vitro. The latter work utilized neural
cells derived from embryonic stem and embryonal carcinoma cells in vitro and neural stem cells from mouse forebrain. In all of
these contexts, geminin antagonized the ability of neural basic helix-loop-helix (bHLH) transcription factors to activate transcriptional programs promoting neurogenesis. Furthermore, geminin promoted a bivalent chromatin state, characterized by the
presence of both activating and repressive histone modifications, at genes encoding transcription factors that promote neurogenesis. This epigenetic state restrains the expression of genes that regulate commitment of undifferentiated stem and neuronal
precursor cells to neuronal lineages. However, maintaining geminin at high levels was not sufficient to prevent terminal neuronal differentiation. Therefore, these data support a model whereby geminin promotes the neuronal precursor cell state by modulating both the epigenetic status and expression of genes encoding neurogenesis-promoting factors. Additional developmental
signals acting in these cells can then control their transition toward terminal neuronal or glial differentiation during mammalian neurogenesis.

Yellajoshyula et al.

MATERIALS AND METHODS
Xenopus. Preparation of capped mRNAs encoding neurogenin (Ngnr1),
Ngnr1-glucocorticoid receptor (Ngnr1-GR), and geminin⌬coil, Xenopus
embryo microinjection, embryo in situ hybridization, and ectodermal explant isolation were performed as previously described (11, 21). For microarrays, 10 pg Ngnr1-GR with or without 100 pg Gem⌬coil RNA was
injected into each cell of a 2-cell embryo and explant isolation, treatment,
and subsequent microarray analysis were performed as previously described (21).
Cell culture. Culture of ES cells and generation of stable clonal lines,
induction of Gem overexpression (OE) and knockdown (KD), and production of neuronal progenitors and differentiation into neuronal lineages (using N2B27 medium and monolayer culture) were performed as
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previously described (30, 31). Culture of P19 cells and P19 cell differentiation into neuronal lineages using retinoic acid (RA) were done as previously described (29). P19 cells were transfected with US2MT-Ngn2,
US2MT-Neurod1 (a kind gift of David L. Turner), or US2MT-geminin
expression vectors; gene expression was driven from the human ubiquitin
C promoter (US2), and proteins contained an amino-terminal 6⫻Myc
tag (MT) as previously described (21). For generating P19 stable clonal
lines overexpressing doxycycline (Dox)-inducible geminin, we used the
Tet-Express inducible expression system (Clontech) to generate stable,
clonal lines of P19 cells that carried both the prtTA and pTRE-geminin
plasmids. Reverse transcription and quantitative reverse transcriptionPCR (qRT-PCR) from Xenopus ectodermal explants and P19 and ES cells
and immunocytochemistry (ICC) in ES cells were done as previously described (11, 21, 30). Primers for qRT-PCR and antibodies for ICC are
described in Table S1 in the supplemental material.
Lentiviral production and transduction. Production of lentiviral
particles from pGIPZ geminin microRNA-adapted short hairpin RNA
(shRNAmir) (Open Biosystems) was done in 293T cells. The day before
the transfection, 293T cells were seeded in a 6-well dish. Transfection was
done with Fugene 6 (Roche) according to the manufacturer’s instructions
using 1 g of the lentiviral transfer vector (pGIPZ-geminin shRNAmir)
and 1.1 g of the second-generation lentiviral packaging vector combination (1 g of delta-8.9 and 100 ng of pVSV-G) (Addgene). After 48 h, the
supernatant containing the virus was collected, and 105 primary neural
stem cells were infected with 100 l of lentiviral supernatant overnight,
followed by medium change and puromycin (0.5 g/ml) selection to isolate a pure population of geminin knockdown primary NSCs.
qChIP. Quantitative chromatin immunoprecipitation (qChIP) was
done as described in detail previously (30). Briefly, sheared chromatin
(sonicated to 200 to 500 bp) was obtained from 2 ⫻ 106 ES or P19 cells that
were fixed in 1% formaldehyde (Sigma) in Dulbecco modified Eagle medium (DMEM) plus 5% fetal bovine serum (FBS). Chromatin was incubated with 5 g antibody or with a corresponding isotype-matched nonspecific antibody (IgG) using Dynabeads (Invitrogen) as per the
manufacturer’s instructions. Antibodies used for ChIP are described in
Table S1 in the supplemental material. After washing, elution, and crosslink reversal, DNA from each ChIP sample and the corresponding input
sample was purified and further analyzed using quantitative PCR (qPCR).
Each ChIP sample and a range of dilutions of the corresponding input
sample (0.01% to 5% input) were quantitatively analyzed with gene-specific primers using the 7500 Fast real-time PCR detection system (ABI)
and SYBR Advantage qPCR premix (Clontech). qChIP data for each
primer pair are represented as percent input by calculating amounts of
each specific DNA fragment in immunoprecipitates (and in their corresponding isotype-matched nonspecific antibody [IgG] control immunoprecipitation) relative to the quantity of that fragment in input DNA. The
final values represent the percent input for the antibody of interest after
subtraction of the percent input value obtained for a control immunoprecipitation of the same sample with isotype-matched nonspecific antibody
(IgG). Gene-specific primer sequences used for ChIP and the genomic
location of the resulting amplicon with respect to the transcription start
site (TSS) are indicated in Table S1 in the supplemental material.
RNA-seq. Total RNA was isolated from Gem KD cells differentiated in
N2B27 medium for 5 days with or without addition of 500 ng/ml Dox for
Gem knockdown from day 3. These samples were used for RNA-seq analysis (Illumina HiSeq2000 platform) by the Genome Technology Access
Center (GTAC) at Washington University School of Medicine, St. Louis,
MO. Three independent RNA-seq experiments were conducted to generate paired control (no-Dox) and geminin knockdown (plus-Dox) samples, and these were analyzed using TopHat and Cufflinks/Cuffdiff (26).
Transcripts were considered differentially expressed upon Gem knockdown if data met statistical significance cutoffs in Cuffdiff (i.e., sufficient
sequence alignments were obtained for analysis and the transcript had a
significant change in FPKM value [normalized transcript abundance;
fragments per kb of exon per million fragments mapped] between the
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rogenesis (24). However, in another study, loss of geminin had no
effect on the cycling NSC population in the subventricular region
and hippocampal dentate gyrus, nor did it affect the ability of
these NSCs to proliferate or further differentiate into neuronal
and glial cell types in vitro (19). Another recent study reported
complex actions of geminin during mammalian neurogenesis,
where both knockdown and overexpression of geminin resulted in
decreased numbers of Sox3-positive neural precursor cells in the
mouse embryo. Likewise, geminin knockdown resulted in the premature appearance of ␤-III tubulin-positive cells, while overexpression of geminin also increased numbers of ␤-III tubulin-positive cells (3). These results suggest that geminin may have a
context-dependent role in regulating the commitment and differentiation of mammalian neural progenitor cells, unlike Xenopus
primary neurogenesis, where geminin unequivocally promotes
neural precursor maintenance and blocks neuronal differentiation. It is difficult to understand the basis of the complex and
dissimilar results obtained upon manipulating Gem’s activities
during mammalian neurogenesis, in part because of the gap in our
understanding of the mechanism by which Gem regulates neurogenesis.
Here, we assessed geminin’s activity in neural precursor cells at
a mechanistic level, determining its effects on the transcriptional
and epigenetic status of genes encoding transcription factors that
promote neurogenesis and on the transcriptional activity of these
factors. We found that geminin antagonizes the ability of neural
bHLH transcription factors to activate transcriptional programs
during neuronal commitment and differentiation. These effects
are seen both during Xenopus primary neurogenesis and in mammalian neural precursor cells undergoing neurogenesis in vitro. At
neural bHLH target genes, Gem regulates both the retention and
levels of enrichment of PcG proteins and of the PcG-mediated
repressive trimethylation of H3K27 (H3K27me3). Gem’s ability
to inhibit gene expression during neurogenesis correlates with an
active role in maintaining a bivalent epigenetic state at these neural gene promoters, whereby they maintain high levels of both
activating H3K4me3 and repressive H3K27me3 methylation. This
epigenetic signature is characteristic of the poised but repressed
state used to restrain the expression of developmental genes in
undifferentiated stem and precursor cells (1, 16). However, maintaining geminin at high levels is not sufficient to prevent ES cellderived neural precursor cells or NSCs obtained from mouse forebrain from undergoing terminal neuronal differentiation.
Therefore, we propose that geminin contributes to restraining
gene programs that drive neuronal commitment in mammalian
neural precursor cells and that its activity is subject to additional
molecular cues to control neuronal differentiation.

Geminin Regulates Neuronal Gene Transcription

RESULTS

Geminin antagonizes neural bHLH transcription factor-regulated gene expression programs during neurogenesis. Prior
work has demonstrated that geminin plays an important role in
regulating neural development and neuronal differentiation during primary neurogenesis in the Xenopus embryo (9, 20). As Gem
is a nuclear protein with known interactions with chromatin-regulatory proteins, we hypothesized that Gem’s role involves effects
on transcriptional regulation of genes that control neurogenesis.
Therefore, we tested whether Gem could antagonize transcriptional responses to neural bHLH transcription factors in the Xenopus embryo. As in our prior work, we controlled transcription
factor activity by using a variant of the Xenopus neurogenin
(Ngnr1) transcription factor fused to the ligand binding domain
of the human glucocorticoid receptor (GR) (21). Prior to addition
of the ligand dexamethasone (DEX), this fusion protein is sequestered in the cytoplasm and remains transcriptionally inactive (8).
Upon DEX addition, Ngnr1-GR translocates into the nucleus and
regulates target genes. We induced Ngnr1-GR activity in the presence of the protein synthesis inhibitor cycloheximide, which
blocks translation of secondary targets whose expression is regulated by primary target proteins. This approach allowed us to
identify 57 direct transcriptional targets of Ngnr1 (21) (see Table
S2 in the supplemental material).
Here, we combined this manipulation with overexpression of
geminin, using a Gem variant (geminin⌬coil) that lacks the Cdt1
interaction domain. In our prior work, this variant maintained
Gem’s ability to inhibit neuronal differentiation in Xenopus and
had no effects on cell cycle progression or cell death (11, 22).
Therefore, it can be used to assess Gem’s ability to antagonize
Ngnr1-mediated transactivation of its targets, while precluding
indirect effects stemming from perturbation of the cell cycle. Simultaneous coexpression of Ngnr1-GR with geminin⌬coil
blocked Ngnr1-mediated activation of 44 of the 57 target genes
(77%) (see Table S2 in the supplemental material). We confirmed
Gem’s ability to repress Ngnr1-mediated activation of a group of
these genes in ectodermal explants (Fig. 1A). We also injected
Xenopus embryos at the two-cell stage with RNA encoding Ngnr1
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(non-GR fused), with or without Gem⌬coil RNA (and with ␤-galactosidase RNA coinjected as a lineage tracer, visualized as blue
staining and oriented to the right in Fig. 1B). We assessed the in
vivo effects at the early neurula stage (stage 14 to 15) by in situ
hybridization for Ngnr1 target genes (Calponin, Dll1, Ebf3,
Cbfa2t2, Myt1, Neurod4, and Amotl1 genes; purple stain)
(Fig. 1B). Coinjection of Gem suppressed the Ngnr1-activated
expression of all of these target genes in the in vivo context of the
Xenopus embryo. From these data, we concluded that Gem antagonizes a significant portion of the Ngnr1-activated transcriptional
program, which could account for Gem’s ability to block primary
neuronal differentiation in the Xenopus embryo.
In mammalian P19 embryonal carcinoma cells, overexpression of neural bHLH proteins such as Neurod1 and neurogenin 2
(Ngn2) (4) or treatment with retinoic acid (RA) (29) promotes
neuronal commitment and differentiation. We wanted to test
whether Gem’s ability to antagonize neural bHLH-driven transcriptional programs and neuronal differentiation is a function
also observed in mammalian cells. Transfection of P19 cells with
expression plasmids for the neuronal bHLH protein Neurod1 or
Ngn2 or differentiation in defined medium supplemented with 5
M RA (see Materials and Methods) induced the expression of
previously defined Neurod1 and Ngn2 target genes (Fig. 1C to E)
(21). However, simultaneous expression of Gem along with Ngn2,
Neurod1, or RA treatment suppressed expression of all of these
genes to various degrees (20 to 60%) (Fig. 1C to E). These results
indicate that in mammalian cells, as in the Xenopus embryo, Gem
antagonizes neural bHLH-driven transactivation of target genes
that promote neurogenesis.
Changes in the epigenetic state of neurogenesis-regulatory
genes during neuronal commitment. The ability of geminin to
antagonize neural bHLH-driven neurogenesis, both in mammalian cells and in the Xenopus embryo, suggests a fundamental
mechanism for Gem-mediated transcriptional regulation of genes
that promote neurogenesis or are associated with neuronal commitment. Furthermore, we previously found that Gem regulates
the chromatin structure of neural genes as pluripotent ES cells
undergo the initial process of neural fate acquisition (30). Therefore, we hypothesized that Gem regulates chromatin structure at
genes that promote neurogenesis, altering their ability to be transactivated by bHLH transcription factors. To test this hypothesis,
we focused on chromatin-regulatory protein complexes and histone modifications that were likely to be involved in regulation of
gene expression in neural precursors. We selected three candidate
genes (Neurod1, Ebf2, and Dll1 genes) whose ability to be transactivated by neural bHLH proteins during neurogenesis was antagonized by Gem both in Xenopus and in P19 cells. Interestingly,
all of these genes are in a bivalent state in pluripotent ES cells,
indicating that their expression is subject to epigenetic regulation
during development (1, 2).
Using multiple primer pairs at a 1-kb resolution from 5 kb
upstream to 5 kb downstream, relative to the transcription start
site, we initially defined the location and temporal changes in regulatory protein occupancy and histone modification status at the
Neurod1 locus in undifferentiated P19 EC cells (day 0) and at day
4 of RA-mediated neuronal differentiation (Fig. 2A). We found
that the PcG repressor complex, as represented by the PcG subunits Suz12 and Mel18, was highly enriched at the Neurod1 transcription start site (TSS) in undifferentiated P19 cells, when the
gene is not expressed. The PcG-mediated repressive histone mod-
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no-Dox and plus-Dox sample pairs) in at least two of the three independent experiments.
NSC derivation and differentiation. Neural stem cells (NSCs) were
derived from embryonic brain tissue as previously described (18). NSCs
were derived from ES cells with modifications to the same protocol (18).
Briefly, ES cells were plated for monolayer differentiation in N2B27 medium for 7 days as previously described (31). After 7 days, cells were
collected and plated for neurosphere formation in suspension dishes in
modified N2B27 medium supplemented with 2⫻ N2 medium (Invitrogen) for 1 to 2 weeks. The neurospheres formed by this procedure were
plated on laminin-coated dishes in NSC growth medium (18) supplemented with 20 ng/ml Fgf2 and 20 ng/ml epidermal growth factor (EGF)
for 1 week. NSCs derived from these neurospheres were further propagated. Neuronal and glial differentiation of both primary and ES-derived
NSC cells was done as previously described (18). Briefly, NSCs were plated
in NSC growth medium with 2% FBS for 3 days to derive glial fibrillary
acidic protein (GFAP)-positive glial cells. For neuronal cells, the NSCs
were plated in DMEM-F12 medium supplemented with 1XB27, 1XN2,
and 5 ng/ml Fgf2 for 3 days, after which the same medium without Fgf2
supplementation was used.
Accession numbers. The microarray and RNA-seq data have been
deposited into the Gene Expression Omnibus under accession numbers
GSE39657 and GSE39658 (SuperSeries GSE39673).

Downloaded from http://mcb.asm.org/ on January 11, 2014 by guest
FIG 1 Geminin antagonizes neurogenin-dependent target gene transactivation during neurogenesis in Xenopus and in P19 EC cells. (A) qRT-PCR analysis of
target gene activation by Ngnr1. Xenopus Ngnr1-GR was overexpressed in Xenopus embryonic ectoderm explants (animal caps), with or without coexpressed
Gem⌬coil. Upon DEX treatment, Ngnr1-GR induced expression of its target genes, as detected by quantitative RT-PCR. This was suppressed by coexpression of
Gem⌬coil. Expression is represented relative to values for uninduced (without DEX) Ngnr-GR-injected explants. (B) Gem suppresses Ngnr1-induced overexpression of its target genes in the Xenopus embryo. One bilateral half of each embryo was injected with capped mRNA encoding Ngnr1 with or without coinjection
of Gem⌬coil, with coinjection of a ␤-galactosidase lineage tracer mRNA (detected as blue X-Gal [5-bromo-4-chloro-3-indolyl-␤-D-galactopyranoside] staining), by injecting one cell at the two-cell stage as previously described (20). Embryos were raised to neurula stages (stages 14 and 15), and in situ hybridization with
the indicated probes was performed (purple stain). Ngnr1 induced ectopic expression of all 7 target genes tested on the injected side (oriented to the right), while
Gem⌬coil coinjection suppressed this Ngnr1-induced gene expression. (C to E) Geminin represses neural bHLH-driven target gene transactivation in P19 EC
cells. Expression of neural bHLH target genes was induced in P19 cells by transfection of expression constructs for Neurod1 (C) or Ngn2 (D) or by treatment with
5 M RA for 4 days (E), with or without overexpression of Gem (see Materials and Methods). qRT-PCR analysis defined relative expression levels for the genes
shown, expressed as a ratio of their expression level with Gem overexpression versus the control (with Neurod1, Ngn2, or RA but without Gem overexpression).
At least three independent experiments were performed for each gene analyzed, and a representative result, with the qRT-PCR performed in triplicate, is shown.
Error bars indicate standard deviations.
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histone modifications indicated. The x axis scans the Neurod1 locus from 5 kb upstream to 4.5 kb downstream, relative to the transcription start site (TSS) (kb
0), and enrichment at each position is indicated as normalized (IgG-subtracted) percent input, as described in Materials and Methods. ChIP was performed in
undifferentiated P19 cells (red) (day 0) or after 4 days of neuronal commitment induced by RA treatment (green). The locus is enriched for PcG proteins (Suz12
and Mel18), H3K27me3, and HDAC1 in undifferentiated cells, while becoming highly enriched for modifications associated with transcriptional activation
(H3K4me3 and H3K9ac) during neurogenesis. (B) Temporal changes in relative levels of the bivalent histone modifications H3K27me3 and H3K4me3 and of
PcG proteins (Suz12 and Mel18) at the Neurod1 locus during days 0 to 5 of neuronal commitment of P19 cells. Percent change in enrichment at the promoter
is shown, relative to day 0. (C) Chromatin immunoprecipitation for the PcG proteins (Suz12 and Mel18) and for H3K27me3 is shown for the neurogenesisrelated Ebf2 and Dll1 genes in P19 EC cells. As above, the x axis scans the region flanking the TSS and enrichment at each position is indicated as normalized
percent input. (D) P19 EC cells underwent neurogenesis in RA for 4 days, and changes in enrichment by day 4 are shown as a percent change relative to
undifferentiated day 0 EC cells for the indicated proteins/histone modifications. Changes in Mel18, Suz12, H3K27me3, H3K4me3, and H3K9ac enrichment were
assessed at kb ⫺1.0 for Ebf2 and 0 (TSS) for Dll1, corresponding to regions of strong PcG binding in EC cells (B).

ification H3K27me3 and the histone deacetylase 1 (HDAC1) were
also enriched at the locus at this time (Fig. 2A). Neurod1 expression increases between days 2 and 5 of neuronal differentiation,
and this corresponds to a 90% loss in enrichment of these PcG
proteins (Suz12 and Mel18) and HDAC1 and a 60% decrease in
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H3K27me3 enrichment, relative to those in undifferentiated P19
cells (Fig. 2A and B). Neurod1 is bivalently marked with both the
activating H3K4me3 and the repressive H3K27me3 modification
in undifferentiated P19 cells (Fig. 2A and B), and enrichment of
the locus for histone modifications that correlate with active gene
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FIG 2 Epigenetic regulation of neurogenesis-related genes during neuronal commitment of P19 cells. (A) Chromatin immunoprecipitation for the proteins and

Yellajoshyula et al.

transcription (H3K4me3, acetylation of histone H3K9 [H3K9ac])
increases prominently by day 4 to 5 (Fig. 2A and B). Therefore,
activation of Neurod1 during RA-mediated P19 differentiation is
associated with the loss of PcG protein binding and H3K27me3
histone modification followed by the transition to an H3K4me3only monovalent state. Several genome-wide studies utilizing human and mouse ES cell systems have demonstrated that PcG complexes and the PcG-regulated H3K27me3 histone modification
constitute an epigenetic mechanism for regulating the expression
of developmental genes, including all of our candidate neurogenesis regulatory genes (NeuroD1, Ebf2, and Dll1 genes) (1, 2, 15).
For the Ebf2 and Dll1 genes, we likewise confirmed that PcG and
H3K27me3 were enriched around the TSS in undifferentiated P19
EC cells, while this enrichment decreased during 4 days of neuronal commitment (Fig. 2C and D). This decrease in PcG protein
binding and H3K27me3 modification corresponds with increases
in expression of these and other bHLH target genes by day 4,
relative to levels found in undifferentiated P19 cells (Fig. 3A).
Therefore, activation of expression of these neurogenesis-regula-
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tory genes involves loss of PcG-mediated repression and a transition from a bivalent modification state to a chromatin state where
the locus is enriched for modifications (H3K4me3 and H3K9ac)
that are conducive for active gene transcription.
Geminin maintains the chromatin of neurogenesis-related
genes in a bivalent state. Having established how regulatory proteins and histone modifications change at these loci during neuronal differentiation, we tested the effects of maintaining high
Gem levels in these cells while inducing them to undergo neuronal
commitment. We constructed stable clonal lines of P19 EC cells
enabling doxycycline (Dox)-inducible Gem overexpression (Gem
OE) (Fig. 3B). We performed Gem OE during 4 days of neuronal
commitment and assessed enrichment of Suz12, H3K27me3,
H3K4me3, and H3K9ac at these loci with Gem OE versus without
(with or without Dox). Gem OE resulted in a 4- to 8-fold increase
in Suz12 enrichment at the three loci tested and a 2-fold increase
in H3K27me3 (for Neurod1 and Ebf2) (Fig. 3C). Maintaining
high levels of Gem during days 0 to 4 of neuronal commitment also consistently increased H3 acetylation (H3K9ac) and
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FIG 3 Geminin regulates the epigenetic state of neural genes during neurogenesis in P19 cells. (A) qRT-PCR was performed for the genes indicated during 7 days
of neuronal commitment of P19 EC cells, and the results were represented as a heat map using Spotfire. Expression levels of neurogenesis-related genes, including
those selected for ChIP analysis (Neurod1, Ebf2, and Dll1 genes), increase by day 4 of neuronal commitment. (B) Generation of doxycycline-inducible P19 EC
cell lines. Stable clonal lines of P19 cells that overexpress Gem in a Dox-inducible manner were created using a doxycycline-inducible expression system
(Clontech). Stable lines of P19 cells that express reverse Tet transactivator protein (rtTA) from the CMV promoter were transfected with a bidirectional vector
(pBI-eGFP) that expresses Flag-tagged Gem and enhanced green fluorescent protein (eGFP) under control of a tetracycline-response element (TRE) and
neomycin resistance under control of a simian virus 40 (SV40) promoter. Multiple stable clonal lines were selected (using G418 for neomycin resistance). These
stable P19 lines were tested for Dox-dependent inducible overexpression of Flag-tagged Gem. (C) Gem overexpression during 4 days of neuronal commitment
of P19 cells increases enrichment for both modifications associated with gene repression (PcG protein Suz12 and H3K27me3), and modifications associated with
transcriptional activation (H3K9ac and H3K4me3), while enrichment for unmodified histone H3 is unchanged by Gem OE. Fold change in enrichment at the
promoter with (⫹Dox) versus without (⫺Dox) Gem overexpression is shown for three neural genes.
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scriptome analysis by deep sequencing (RNA-seq) in Gem knockdown cells. RNA was extracted from Gem KD cells after cells underwent neurogenesis for 5 days in N2B27 medium with or
without Dox-induced Gem knockdown from day 3 to 5. Gemregulated genes were then identified using RNA-seq (Materials
and Methods). A total of 388 genes were differentially regulated by
Gem KD, which represented 273 significantly upregulated and
115 downregulated genes (see Table S3 in the supplemental material). We used Gene Ontology (GO) enrichment analysis to assess functional roles of the genes that were upregulated upon Gem
knockdown in order to understand the biological significance of
gene regulation by Gem in neural progenitors. Gem KD-upregulated genes were highly enriched for genes involved in neuronal
commitment, differentiation, and function (e.g., neuron projection) and transcription factor activities, including bHLH transcription factors (P ⫽ 6.5E⫺06) (Fig. 5B). Examples of these genes
are shown in Fig. 5C and include a number of transcription factors
with known roles in neurogenesis (Ascl1, Ebf1/3, Hes6, Myt1,
Neurod4, Ngn1, and Nhlh1/2) as well as other molecules with
known roles in neuronal development and function (Fig. 5C).
Some of these were Ngnr1 targets also repressed by Gem in Xenopus (Ascl1, Ebf3, Hes6, Myt1, and Neurod4) (Fig. 1; see Table S2 in
the supplemental material). In contrast, a distinct group of genes
showed decreased expression upon Gem knockdown; these included genes involved in cell adhesion/epithelial function. Therefore, global gene expression analysis of Gem-regulated genes supported our hypothesis that Gem’s major role in cells at these stages
is to restrain the expression of transcription factors involved in
neurogenesis to maintain the progenitor cell state and control
neuronal differentiation.
We next used chromatin immunoprecipitation to evaluate this
regulation at the chromatin level. During neuronal differentiation
of ES cells, we compared enrichment for Suz12, H3K27me3, and
H3K4me3 at the promoters of candidate neuronal genes on day 0
(ES) cells versus day 7. We observed a 90% reduction in enrichment of Suz12 and a 60 to 80% reduction in enrichment of
H3K27me3 by day 7 of neurogenesis at the Ascl1, Dll1, Ebf2, Ebf3,
Hes5, nestin, and Neurod1 loci (Fig. 6A and B). There was a corresponding gene-dependent 1.5- to 5-fold increase in the activating histone mark H3K4me3 at these loci (Fig. 6C). We also performed ChIP under conditions of Gem overexpression and
knockdown in ES-derived neural precursor cells. Similar to the
results for P19 EC cells, Gem overexpression in neural precursor
cells from day 3 through day 7 increased H3K27me3 enrichment
1.5- to 4-fold at these neurogenesis-related genes, relative to the
control without Dox (Fig. 6D). In contrast, Gem knockdown in
ES-derived neural precursor cells resulted in a 2-fold decrease in
H3K27me3 enrichment (Fig. 6D). We also analyzed the activating
mark H3K4me3 under conditions of Gem OE and KD during
neuronal differentiation and observed no strong change in enrichment at our candidate genes (Fig. 6E). These observations were
consistent with our findings in P19 cells and with the RNA-seq
data, which indicated that many transcription factors with roles in
neurogenesis were under negative regulation by Gem in neural
precursor cells. Therefore, high Gem levels contribute to repressing the expression of genes that promote neurogenesis and neuronal differentiation, and this correlates with Gem’s ability to promote retention of the H3K27me3 modification in neural
precursor cells, which would be expected to restrain gene expression.

mcb.asm.org 4555

Downloaded from http://mcb.asm.org/ on January 11, 2014 by guest

H3K4me3 modification (Fig. 3C). In the same experiments, Gem
overexpression did not affect levels of unmodified histone H3 protein enrichment on chromatin at these loci (Fig. 3C). These data
suggest that Gem acts in this context by enhancing the enrichment
of specific epigenetic modifications that play a regulatory role in
controlling gene expression, rather than by generally increasing
overall chromatin accessibility. Together, these results demonstrate that Gem can promote a bivalent histone modification state
at genes that promote neurogenesis, with high levels of both activating H3K4me3 and repressing H3K27me3 histone modifications. Developmental genes that promote cell specification, commitment, and differentiation often have this characteristic histone
modification status in undifferentiated stem and progenitor cells.
Therefore, Gem’s ability to promote this epigenetic modification
state could contribute to Gem’s ability to restrain neural bHLHdriven transactivation of these loci during neuronal commitment.
As described above, we found that Gem blocks bHLHdriven transcriptional programs in both Xenopus embryos and
P19 cells. We wished to see whether Gem could likewise regulate neuronal commitment and differentiation in neural stem
cells (NSCs) that were derived from ES cells or obtained from
the mouse embryonic forebrain (embryonic day 12.5 [E12.5]).
These NSCs can be grown as a self-renewing cell population in
culture or can be efficiently driven to undergo terminal neuronal or glial differentiation. Therefore, they represent ideal
models for assessing regulation of differentiation from lineagerestricted but undifferentiated neural precursors. Mouse ES
cells plated in serum-free medium (N2B27) as a monolayer for
21 days undergo terminal differentiation into neurons, as indicated by staining for ␤-III tubulin, a marker for mature neurons (31). Reproducible transcriptional and phenotypic
changes occur during this time: By day 4, approximately 60% of
cells in the culture are immunopositive for Sox1 and Pax6,
markers of neural precursors, and most cells lose expression of
Oct4, a marker of the pluripotent ES state (Fig. 4A to D). Relative to levels found in ES cells, Gem expression decreases considerably at the protein level by day 4, while Gem expression
levels are ⬍10% of expression levels found in ES cells by day 7
(Fig. 4E and F). During the same time window, expression of all
of our candidate neurogenesis-regulatory genes increases exponentially (Fig. 4G). Plating these neural precursors at day 7
onto poly-D-lysine/laminin-coated dishes and further culture
(for 2 weeks) result in phenotypic changes characteristic of
neuronal differentiation, with neurite outgrowth and staining
for mature neuronal fate markers such as ␤-III tubulin
(Fig. 4H).
We overexpressed Gem during days 3 to 7 of neurogenesis in
this system to test whether maintaining high Gem levels would
repress expression of neurogenesis-related genes, as was seen in
P19 cells and Xenopus embryos. For this purpose we used clonal
ES cell lines that overexpress Gem by 2- to 4-fold in a doxycycline
(Dox)-inducible manner as previously reported (30). Gem overexpression (OE) between days 3 and 7 suppressed the expression
of many of our candidate neurogenesis-promoting genes (Fig.
5A). Using corresponding cell lines for Dox-inducible expression
of shRNAmirs directed against Gem (Gem knockdown [KD])
(30), we also performed Gem knockdown (by 80%) during days 3
to 7 of neurogenesis. This resulted in increased expression of the
same neurogenesis-regulatory genes (Fig. 5A). To analyze these
phenomena in a comprehensive manner, we next performed tran-
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have lost pluripotency marker expression (fewer than 20% Oct4-positive cells) and a majority of cells have been converted into neural precursors expressing Sox1
and Pax6 (40 to 60% Sox1-positive and 60% Pax6-positive cells) as shown by immunocytochemistry (A and B) and quantitated in the graphs (C and D). (E and
F) During neurogenesis in this system, Gem levels decline steadily, with more than an 80% decrease by day 7, as shown by Western blotting (E) and quantitated
in the graph (F). (G) During 10 days of N2B27 culture, expression of neurogenesis-regulatory genes increases exponentially, as demonstrated by qRT-PCR
analysis. Increased expression of these genes is accompanied by downregulation of Gem. (H) After 2 weeks of differentiation in N2B27 medium, cells expressing
the neuron-specific ␤-III tubulin marker (TuJ1) are apparent.

Geminin is dispensable for controlling neuronal differentiation of ES- and brain-derived neural precursor cells. We next
induced these ES-derived neural precursor cells to undergo neuronal differentiation in monolayer culture under conditions in
which Gem expression was unperturbed versus conditions of Gem
overexpression. However, despite Gem’s effects during neurogenesis on the epigenetic modification state and expression of genes
that promote neuronal commitment and differentiation, we observed no change in the number of ␤-III tubulin-positive cells or
the overall phenotype of these cells with or without Gem OE (data
not shown). Corroborating this observation, Gem-mediated repression of neuronal genes was still observed at day 10 but did not
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persist to day 14, by which time the majority of the cells are terminally differentiated (Fig. 7A and B). This was seen either when
Dox-induced Gem overexpression was performed from day 3
through day 14 or upon transient Gem overexpression from day
10 to 14 (Fig. 7A and B and data not shown). These results suggest
that while Gem is capable of antagonizing neuronal gene expression in neural precursor cells, its activity is not sufficient to prevent differentiation under conditions that promote neuronal differentiation.
To further assess Gem’s activities in neural precursor cells, we
isolated neural stem cells (NSCs) from embryonic day 12.5
(E12.5) mouse forebrain (telencephalon) and tested whether Gem
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FIG 4 ES cells undergoing neurogenesis and neuronal differentiation in N2B27 monolayer culture. (A to D) By 5 days of culture in N2B27 medium, most ES cells
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mitment and differentiation in ES cells undergoing neurogenesis. (A) Doxmediated overexpression (OE) (blue) or knockdown (KD) (red) was performed during days 3 to 7 of neurogenesis in N2B27 monolayer culture, and
relative expression of the genes indicated was determined by qRT-PCR (expressed as fold change in expression with and without Dox). Gem OE suppressed and Gem KD enhanced expression of neurogenesis-promoting genes.
(B and C) Transcriptome profiling of ES-derived neuronal precursor cells (day
5) following Gem knockdown from day 3 to 5 was performed by RNA-seq. (B)
Enriched Gene Ontology (GO) term clusters for the gene sets that had increased (upregulated) and decreased (downregulated) expression upon Gem
knockdown are shown (terms and P values were determined using the DAVID
Bioinformatics Suite). (C) Examples of genes with significantly changed expression upon Gem knockdown in ES-derived neuronal precursor cells (RNAseq analysis). Gem KD enhanced expression of genes associated with neurogenesis and neuronal differentiation and function.
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DISCUSSION

Geminin affects the epigenetic state and expression of neurogenesis-regulatory genes in neural precursor cells. Previously,
we found that Gem blocks terminal neuronal differentiation during Xenopus neurogenesis (20). Here, we demonstrated that Gem
represses a major fraction of the transcriptional program driven
by neural bHLH transcription factors during Xenopus primary
neurogenesis. This could account, at least in part, for Gem’s ability
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FIG 5 Geminin restrains the expression of genes that promote neuronal com-

regulates NSC maintenance or ability to undergo terminal differentiation into neurons or glia (see Materials and Methods). We
transduced NSCs with a lentiviral construct for expression of an
shRNAmir directed against Gem, under the control of the cytomegalovirus (CMV) promoter (see Materials and Methods); this
resulted in ⬃95% knockdown of Gem at the protein level (Fig.
7C). As controls, NSCs were transduced with a scrambled target
sequence (nonspecific [NS]), and another shRNAmir construct
directed against a distinct targeting sequence in Gem was also used
to control for off-target effects. Gem knockdown NSCs could be
propagated for multiple generations in the same manner as the
parental NSC cells (data not shown). Wild-type (NS-transduced)
and Gem KD NSCs also formed neurospheres of similar size, suggesting that Gem knockdown did not impair NSC proliferation or
self-renewal (Fig. 7D). We also assessed changes in the expression
of two neurogenesis-regulatory genes (Ebf2/Neurod1) during
neuronal differentiation. Expression of these genes increased to a
similar extent during induction of neuronal differentiation in NS
or Gem KD NSCs (Fig. 7E). This suggested that Gem loss did not
alter neural gene expression changes in NSCs during neuronal
differentiation. Therefore, Gem loss in embryonic NSCs does not
alter their capability to self-renew or their expression of neuronal
fate-promoting genes.
As Gem knockdown did not appear to alter NSC self-renewal,
we wanted to assess whether forced overexpression of Gem in
NSCs could affect their ability to self-renew and differentiate into
neuronal or glial lineages. For this purpose, we developed neural
stem cell lines from our stable ES cell lines that enable Dox-dependent induction of Gem overexpression (referred to here as NSC
Gem OE) (Fig. 7F) (see Materials and Methods). The Gem OE
NSC cells proliferated in an EGF/Fgf2-dependent manner on
laminin-coated dishes and showed no change in their overt morphology or proliferative potential when Gem OE was induced by
Dox treatment (data not shown). These cells were further differentiated into either neuronal or glial cells (see Materials and Methods) for 3 days, with or without Dox treatment, and we measured
the ability of Gem OE to alter cell differentiation and gene expression. At a morphological level, Dox-dependent Gem OE did not
appear to affect the ability of NSCs to differentiate into neuronal
or glial derivatives (Fig. 7G). We also monitored neuronal differentiation by measuring the expression of the Ascl1, Chrna4, and
Gad1 neuronal marker genes and glial fate by measuring the expression of Gfap, Plp, and S100B. As shown in Fig. 7H and I, no
changes in expression of these genes were observed upon Gem OE
in either differentiation scheme, correlating with the lack of morphological difference between neuronal and glial cells differentiated with versus without Gem OE. Therefore, these results further
confirm our observations that while Gem can transiently repress
neuronal genes during mammalian neurogenesis, manipulation
of Gem levels is not sufficient to alter the differentiation potential
of these cells.
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FIG 6 Geminin regulates the epigenetic state of neurogenesis-regulatory
genes. (A to C) Enrichment was defined by ChIP flanking the promoters of
the Ascl1, Dll1, Ebf2, Ebf3, Hes5, nestin, and Neurod1 loci. These neurogenesis-associated genes show a 90% reduction in Suz12 enrichment (A), a 60 to
80% reduction of H3K27me3 enrichment (B), and a 1.5- to 5-fold increase in
H3K4me3 enrichment (C) by day 7 of neurogenesis, compared
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with enrichment levels at each promoter in undifferentiated ES cells (day 0).
(D) Stable clonal lines of ES cells underwent neurogenesis for 7 days in N2B27
medium, with or without Gem overexpression or knockdown by Dox treatment from day 3 through 7. The fold change in ChIP enrichment for
H3K27me3 at the promoters of the genes shown was determined following
Gem overexpression (blue) or knockdown (red). Gem OE enriched, while
Gem KD diminished, enrichment levels of H3K27me3 at the promoter. (E)
ChIP analysis was conducted to detect H3K4me3 enrichment at neurogenesisregulatory genes upon Dox-inducible Gem overexpression or knockdown
during days 3 to 7 of neurogenesis in N2B27 monolayer culture. Minor
changes in H3K4me3 enrichment occurred in a gene-dependent manner, with
no specific trend across the gene set. Fold change in enrichment at the promoter with (⫹Dox) versus without (⫺Dox) induced Gem overexpression and
knockdown is shown for five neural genes.
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to block neuronal differentiation. We also determined that Gem
can repress bHLH-driven transactivation of many of these same
target genes during mammalian neurogenesis, using both P19 EC
and ES-derived neural precursor cells that were driven to undergo
neuronal commitment and differentiation. Therefore, Gem contributes to the molecular mechanisms restraining neurogenesis in
both Xenopus and mammals. Previously, we showed that Gem also
plays a conserved role in promoting the initial acquisition of neural fate from pluripotent cells (9, 11, 30). These findings are compatible with Gem’s expression in both Xenopus and mammalian
systems: Gem is highly expressed in pluripotent stem cells and
early neural precursors, both in vivo and in vitro, but its expression
is downregulated as proneural bHLH activities increase and the
later aspects of neurogenesis, neuronal commitment, and differentiation occur (20, 23).
In the current study, we observed that Gem’s activities in neural precursor cells correlate with its ability to alter the epigenetic
modification state of genes whose expression increases during
neurogenesis and neuronal differentiation. Specifically, Gem enhanced enrichment of PcG proteins and of the PcG activity-associated histone modification H3K27me3 at genes that encode activities promoting neuronal commitment and differentiation.
Gem was previously shown to interact with members of the PcG
PRC1 complex, including Scmh1, and to functionally cooperate
with PcG activity in Hox gene repression during rostrocaudal patterning of the embryo (12). During the earliest aspects of fate
acquisition of pluripotent embryonic cells in Xenopus, Gem also
repressed nonneural (mesodermal, epidermal, and endodermal)
fate acquisition through mechanisms involving functional cooperativity with PcG (11). Therefore, our results here suggest that
neurogenesis represents another cellular context in which Gem
enhances retention of PcG-mediated repressive modifications to
restrain gene expression.
Interestingly, we found that Gem increased enrichment levels
of both the repressive histone modification H3K27me3 and histone modifications that promote gene transactivation, H3K4me3
and H3K9ac. The coenrichment of target genes by H3K27me3 and
H3K4me3 represents a “bivalent” signature used to retain genes
that promote lineage-specific commitment programs in a poised
but repressed state in stem and precursor cells, including lineagerestricted, undifferentiated neural precursor cells (16). By promoting a bivalent chromatin status, Gem may contribute to maintenance of the neural precursor cell state by restraining the
expression of genes that promote progression through neurogenesis and initiation of neuronal differentiation. Gem can directly
interact with multiple chromatin-modifying complexes, includ-
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FIG 7 Geminin is dispensable for neural stem cell maintenance and control of
neuronal or glial differentiation potential. (A and B) Clonal ES lines were
induced to undergo neuronal differentiation with (⫹Dox) or without (⫺Dox)
inducible overexpression of Gem from day 3 to day 10 (A) or day 14 (B).
Expression levels of five neuronal genes were determined by qRT-PCR and are
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represented as relative expression with (⫹Dox) versus without (⫺Dox) Gem
overexpression. Gem represses neuronal gene expression at day 10, but this
repressive activity is lost by day 14. (C) NSCs derived from the forebrain of a
12.5-day embryo (see Materials and Methods) were transduced with a pGIPZ
control (scrambled shRNAmir, nonspecific [NS]) or with a pGIPZ-Gem
shRNAmir-expressing lentivirus (denoted GemKD) (OpenBiosystems). Gem
knockdown was confirmed using immunocytochemistry (Gem, red; 4=,6=-diamidino-2-phenylindole [DAPI]-stained nuclei, blue) and Western blotting.
(D and E) Gem KD in primary NSCs did not affect neurosphere size (D) or
changes in expression levels of Neurod1 or Ebf2 (E) during 3 days of neuronal
differentiation of NSCs. (F) NSCs were derived from doxycycline-inducible ES
cell lines for overexpression of FLAG-tagged Gem. Endogenous and FLAG
(FL)-tagged Gem are shown by Western blotting after 2 days of Dox treatment.
(G to I) Dox-dependent induction of Gem overexpression in NSCs resulted in
significant increases in Gem expression but did not alter the ability of NSCs to
differentiate into neuronal or glial lineages, as assayed by morphology (G) and
by expression of neuronal (H) or glial (I) genes. Gene expression was measured
by qRT-PCR after 3 days of neuronal and glial differentiation with or without
Gem overexpression.
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ing the PcG repressor complex (potentially via Scmh1) and the
SWI/SNF chromatin-remodeling complex (through its catalytic
subunit Brg1). Gem can also modulate the acetylation status of
neural genes during initial neural fate acquisition of pluripotent
ES cells (12, 20, 30). Gem’s ability to interact with and alter the
activities of multiple chromatin-modifying complexes could enable Gem to perform distinct, context-dependent activities. We
found that Gem promotes a bivalent epigenetic modification
state, characterized by the presence of both activating and repressive epigenetic modifications, at neurogenesis-regulatory genes in
neural precursor cells. These data provide a molecular correlate
for prior phenotypic observations, where Gem was suggested to
restrain terminal neuronal differentiation and promote maintenance of neural progenitor cells (20).
Geminin’s ability to block neuronal differentiation during primary neurogenesis in the Xenopus embryo was dependent on its
interaction with the SWI/SNF catalytic subunit Brg1 (20). Brg1
can interact with neural bHLH transcription factors, and, in the
context of Xenopus primary neuronal differentiation, SWI/SNF
activity is required for proneural bHLH-mediated transactivation
of target genes that regulate neuronal differentiation. In contrast,
it is not clear whether Gem’s ability to interact with Brg1 is functionally relevant to mammalian neurogenesis. Deletion of a Gem
carboxy-terminal motif required for Gem-Brg1 interaction did
not affect Gem’s ability to promote neural gene expression during
initial neural fate acquisition in mammalian cells (30). In addition, neural bHLH-dependent target gene transactivation does
not appear to be strictly dependent on SWI/SNF activity during
neurogenesis in mammals. For example, in P19 cells, we found
that overexpression of a dominant negative form of Brg1 (7) did
not affect the ability of Ngn2 to transactivate expression of target
genes that promote neurogenesis (Neurod1 and Ebf2 genes) (data
not shown). During mammalian neurogenesis, the role of SWI/
SNF remodeling complexes appears to be complex: the transition
from neural progenitor cells to postmitotic neurons is accompanied by an exchange of paralogous forms of several SWI/SNF
complex subunits. This subunit switching alters the functional
properties of the complex, such that one SWI/SNF complex is
involved in maintenance of neural progenitors, while a distinct
complex controls neuronal properties in postmitotic neurons
(10). Distinct SWI/SNF complexes likewise play complex and
context-dependent roles in other aspects of mammalian develop-
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ment, such as pluripotency maintenance, acting as both activators
and repressors of transcription (6, 32). Therefore, the requirement for Gem-Brg1 interaction during primary neurogenesis in
Xenopus, versus the apparent lack of a similar requirement in
mammals, may reflect evolutionary divergence of these activities,
where additional regulatory complexity appears to be utilized to
control mammalian neurogenesis.
Geminin is not sufficient to prevent terminal neuronal differentiation of mammalian neural precursor cells. While Gem
could block neuronal differentiation during Xenopus primary
neurogenesis, results from mammalian work have been conflicting. Here, we found that while Gem transiently repressed the expression of neuronal genes during mammalian neurogenesis,
Gem was not sufficient to alter the differentiation potential of
lineage-restricted neural precursor cells. These results are consistent with the recent observation that Gem loss in mammalian
NSCs in a conditional mouse model did not affect their capability
to self-renew or their differentiation potential in vivo or in vitro
(19). We also found that while Gem increases PcG enrichment
and otherwise alters the epigenetic status of neuronal genes in
neural precursor cells, it did not alter the progression toward terminal neuronal or glial differentiation at either a phenotypic or
molecular level. Therefore, while Gem contributes to establishing
the epigenetic modification state and transcriptional status of
neurogenesis-related genes in neural precursor cells, in these
mammalian contexts, other developmental cues exert significant
and overriding effects to drive the terminal differentiation of these
cells.

